Characterization of cyclic 3', 5'-nucleotide phosphodiesterase activity in an islet cell tumor of the syrian hamster

Ulrich K. Schubart, Linda Udem, Stephen G. Baum, Ora M. Rosen

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

During the purification of cyclic nucleotide phosphodiesterase (diesterase) activity from an insulin-secreting islet cell tumor of the syrian hamster, two soluble diesterases (diesterase I and diesterase II) and a particulate diesterase were resolved. Based on gel filtration, the estimated molecular weights of diesterases I and II were approximately 180,000. All of the diesterases had 'low' (approximately 1 μM) and 'high' (10-20 μM) KM's for both cAMP and cGMP. A heat-stable protein activator was partially separated from the soluble diesterases upon DEAE-cellulose chromatography. The activator enhanced the activity of the soluble diesterase 2 1 2-fold at cyclic nucleotide concentrations of 5 μM. No stimulation of diesterase activity was observed at higher (50-500 uM) substrate concentrations. The following compounds (in order of decreasing potency) inhibited both the soluble and particulate diesterases: papaverine, SQ 20009, xanthine derivatives, diphenylhydantoin, diazoxide, sulfonylureas, nicotinamide and catecholamines. Insulin, proinsulin, prostaglandins E1 and F, secretin, glucagon, colchicine, glucose, streptozotocin and imidazole were all without effect. Sulfhydryl-containing compounds and a number of amino acids enhanced the activity of soluble and paniculate diesterases. These investigations coupled with studies of adenylate cyclase and protein kinase activities, intracellular cyclic nucleotide levels and insulin secretion will provide a basis for understanding the role of cAMP in insulin secretion.

Original languageEnglish (US)
Pages (from-to)227-247
Number of pages21
JournalMolecular and Cellular Endocrinology
Volume1
Issue number3
DOIs
StatePublished - 1974

Fingerprint

3',5'-Cyclic-AMP Phosphodiesterases
Islet Cell Adenoma
Cyclic Nucleotides
Mesocricetus
Tumors
Insulin
Etazolate
Diazoxide
Proinsulin
Adenylate Kinase
DEAE-Cellulose Chromatography
Papaverine
Xanthine
Secretin
Niacinamide
Alprostadil
Phosphoric Diester Hydrolases
Colchicine
Insulin-Secreting Cells
Phenytoin

Keywords

  • cAMP
  • insulin secreting tumor
  • insulin secretion
  • islet cell tumor
  • phosphodiesterase
  • phosphodiesterase activator

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Characterization of cyclic 3', 5'-nucleotide phosphodiesterase activity in an islet cell tumor of the syrian hamster. / Schubart, Ulrich K.; Udem, Linda; Baum, Stephen G.; Rosen, Ora M.

In: Molecular and Cellular Endocrinology, Vol. 1, No. 3, 1974, p. 227-247.

Research output: Contribution to journalArticle

@article{3a8c0fa4c1e44bb2bb82d3c25f705009,
title = "Characterization of cyclic 3', 5'-nucleotide phosphodiesterase activity in an islet cell tumor of the syrian hamster",
abstract = "During the purification of cyclic nucleotide phosphodiesterase (diesterase) activity from an insulin-secreting islet cell tumor of the syrian hamster, two soluble diesterases (diesterase I and diesterase II) and a particulate diesterase were resolved. Based on gel filtration, the estimated molecular weights of diesterases I and II were approximately 180,000. All of the diesterases had 'low' (approximately 1 μM) and 'high' (10-20 μM) KM's for both cAMP and cGMP. A heat-stable protein activator was partially separated from the soluble diesterases upon DEAE-cellulose chromatography. The activator enhanced the activity of the soluble diesterase 2 1 2-fold at cyclic nucleotide concentrations of 5 μM. No stimulation of diesterase activity was observed at higher (50-500 uM) substrate concentrations. The following compounds (in order of decreasing potency) inhibited both the soluble and particulate diesterases: papaverine, SQ 20009, xanthine derivatives, diphenylhydantoin, diazoxide, sulfonylureas, nicotinamide and catecholamines. Insulin, proinsulin, prostaglandins E1 and F1α, secretin, glucagon, colchicine, glucose, streptozotocin and imidazole were all without effect. Sulfhydryl-containing compounds and a number of amino acids enhanced the activity of soluble and paniculate diesterases. These investigations coupled with studies of adenylate cyclase and protein kinase activities, intracellular cyclic nucleotide levels and insulin secretion will provide a basis for understanding the role of cAMP in insulin secretion.",
keywords = "cAMP, insulin secreting tumor, insulin secretion, islet cell tumor, phosphodiesterase, phosphodiesterase activator",
author = "Schubart, {Ulrich K.} and Linda Udem and Baum, {Stephen G.} and Rosen, {Ora M.}",
year = "1974",
doi = "10.1016/0303-7207(74)90031-8",
language = "English (US)",
volume = "1",
pages = "227--247",
journal = "Molecular and Cellular Endocrinology",
issn = "0303-7207",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Characterization of cyclic 3', 5'-nucleotide phosphodiesterase activity in an islet cell tumor of the syrian hamster

AU - Schubart, Ulrich K.

AU - Udem, Linda

AU - Baum, Stephen G.

AU - Rosen, Ora M.

PY - 1974

Y1 - 1974

N2 - During the purification of cyclic nucleotide phosphodiesterase (diesterase) activity from an insulin-secreting islet cell tumor of the syrian hamster, two soluble diesterases (diesterase I and diesterase II) and a particulate diesterase were resolved. Based on gel filtration, the estimated molecular weights of diesterases I and II were approximately 180,000. All of the diesterases had 'low' (approximately 1 μM) and 'high' (10-20 μM) KM's for both cAMP and cGMP. A heat-stable protein activator was partially separated from the soluble diesterases upon DEAE-cellulose chromatography. The activator enhanced the activity of the soluble diesterase 2 1 2-fold at cyclic nucleotide concentrations of 5 μM. No stimulation of diesterase activity was observed at higher (50-500 uM) substrate concentrations. The following compounds (in order of decreasing potency) inhibited both the soluble and particulate diesterases: papaverine, SQ 20009, xanthine derivatives, diphenylhydantoin, diazoxide, sulfonylureas, nicotinamide and catecholamines. Insulin, proinsulin, prostaglandins E1 and F1α, secretin, glucagon, colchicine, glucose, streptozotocin and imidazole were all without effect. Sulfhydryl-containing compounds and a number of amino acids enhanced the activity of soluble and paniculate diesterases. These investigations coupled with studies of adenylate cyclase and protein kinase activities, intracellular cyclic nucleotide levels and insulin secretion will provide a basis for understanding the role of cAMP in insulin secretion.

AB - During the purification of cyclic nucleotide phosphodiesterase (diesterase) activity from an insulin-secreting islet cell tumor of the syrian hamster, two soluble diesterases (diesterase I and diesterase II) and a particulate diesterase were resolved. Based on gel filtration, the estimated molecular weights of diesterases I and II were approximately 180,000. All of the diesterases had 'low' (approximately 1 μM) and 'high' (10-20 μM) KM's for both cAMP and cGMP. A heat-stable protein activator was partially separated from the soluble diesterases upon DEAE-cellulose chromatography. The activator enhanced the activity of the soluble diesterase 2 1 2-fold at cyclic nucleotide concentrations of 5 μM. No stimulation of diesterase activity was observed at higher (50-500 uM) substrate concentrations. The following compounds (in order of decreasing potency) inhibited both the soluble and particulate diesterases: papaverine, SQ 20009, xanthine derivatives, diphenylhydantoin, diazoxide, sulfonylureas, nicotinamide and catecholamines. Insulin, proinsulin, prostaglandins E1 and F1α, secretin, glucagon, colchicine, glucose, streptozotocin and imidazole were all without effect. Sulfhydryl-containing compounds and a number of amino acids enhanced the activity of soluble and paniculate diesterases. These investigations coupled with studies of adenylate cyclase and protein kinase activities, intracellular cyclic nucleotide levels and insulin secretion will provide a basis for understanding the role of cAMP in insulin secretion.

KW - cAMP

KW - insulin secreting tumor

KW - insulin secretion

KW - islet cell tumor

KW - phosphodiesterase

KW - phosphodiesterase activator

UR - http://www.scopus.com/inward/record.url?scp=49349139863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49349139863&partnerID=8YFLogxK

U2 - 10.1016/0303-7207(74)90031-8

DO - 10.1016/0303-7207(74)90031-8

M3 - Article

AN - SCOPUS:49349139863

VL - 1

SP - 227

EP - 247

JO - Molecular and Cellular Endocrinology

JF - Molecular and Cellular Endocrinology

SN - 0303-7207

IS - 3

ER -